• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Symposium turns spotlight on brain research

Bioengineer by Bioengineer
January 6, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

RIVERSIDE, Calif. – The brain is home to two kinds of cells: neurons and glia, with the latter protecting the former. Glia, the stuff between neurons, are important also because they regulate and define neuron-neuron communication.

The study of glia is so intense that an annual symposium held at the University of California, Riverside on how glial-neuronal interactions impact health and disease is in its 10th year.

The next "Glial-neuronal Interactions in Health and Disease" symposium will take place on Friday, Jan. 13, 2017, and is expected to attract about 230 top brain-researchers. Scientists attending the symposium will discuss and present their latest findings in glial-neuronal interactions – now one of the most active pursuits in brain research.

The symposium is from 9:30 a.m. to 6 p.m. in Room 302 of the Highlander Union Building, a short walk from the bell tower on campus. Registration is free for attendees from UC Riverside, non-profit organizations and the media. For others, registration costs $175 per person, which includes lunch. All attendees are requested to register.

"At UC Riverside, we have a novel focus – glial-neuronal interactions applied to a multiplicity of diseases," said Monica Carson, Ph.D., the director of the UCR Center for Glial-Neuronal Interactions (CGNI) and a professor of biomedical sciences in the School of Medicine, who is organizing the symposium. "We look at mechanisms common to all of these diseases, as well as how one disease differs from the rest. Our center is unique in that we examine glial-neuronal interactions at a level that few other centers worldwide do. We are very pleased to host the symposium for the tenth year in a row."

Carson, who is also the chair of Biomedical Sciences, said that glia play prominent and often causative roles in the development of many common neurodegenerative and neurodevelopmental disorders including Alzheimer's disease, autism-spectrum disorders, epilepsy, Huntington's disease, stroke, multiple sclerosis, Parkinson's disease, and schizophrenia.

The keynote lecture will be given at 10 a.m. by Greg Lemke, Ph.D., whose lab has made major contributions to understanding the role that receptor tyrosine kinases (RTKs) play in mammalian development and physiology. Lemke is Françoise Gilot-Salk Professor at the Salk Institute for Biological Studies, where he is a member of the Molecular Neurobiology Laboratory and co-director of the Immunobiology and Microbial Pathogenesis Laboratory. He is also adjunct professor of neurosciences, and biomedical sciences, at UC San Diego. A major focus of his current research is the TAM family of RTKs — Tyro3, Axl, and Mer — and how this family functions in immune regulation, virus infection, and cancer.

See the complete schedule for the symposium.

The Glenn Hatton Lecture at 5 p.m. will be given by Tore Eid, M.D., Ph.D., an associate professor of laboratory medicine and the associate director of the Clinical Chemistry Laboratory at Yale-New Haven Hospital, Conn. Eid's research focuses on the discovery of novel diagnostics and therapeutics of epilepsy, one of the most common chronic neurological disorders in humans. The lecture honors the memory and vision of Glenn I. Hatton, a professor of cell biology and neuroscience at UCR who died in 2009.

###

Founded in 2007, CGNI, the first center in UCR's School of Medicine, facilitates innovative collaborations between neuro- and glial-centric researchers, as well as with researchers from outside the field of neuroscience. The goal is to understand how the central nervous system functions at the molecular level and to identify both risk factors for brain disease and therapeutic targets of intervention for neurodevelopmental, neurodegenerative and neuro-autoimmune disease.

The 10th annual "Glial-neuronal Interactions in Health and Disease" symposium is supported by UCR's School of Medicine, the Graduate Program in Biomedical Sciences, the Graduate Program in Neurosciences, the Glenn Hatton Memorial Fund, and several sponsors.

The University of California, Riverside (http://www.ucr.edu) is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment is now nearly 23,000 students. The campus opened a medical school in 2013 and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Center. The campus has an annual statewide economic impact of more than $1 billion. A broadcast studio with fiber cable to the AT&T Hollywood hub is available for live or taped interviews. UCR also has ISDN for radio interviews. To learn more, call (951) UCR-NEWS.

Media Contact

Iqbal Pittalwala
[email protected]
951-827-6050
@UCRiverside

http://www.ucr.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Sarcopenia: The Future of Muscle Ultrasound?

October 27, 2025

Serum Phosphate Levels Link to Hospital Stay in Neonatal Sepsis

October 27, 2025

Exploring Cathepsin Z’s Role in Prostate Cancer

October 27, 2025

Revealing Hyper-Maturity and Rapid Aging in the Hippocampus

October 27, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1285 shares
    Share 513 Tweet 321
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    310 shares
    Share 124 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    197 shares
    Share 79 Tweet 49
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    134 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sarcopenia: The Future of Muscle Ultrasound?

Serum Phosphate Levels Link to Hospital Stay in Neonatal Sepsis

Exploring Cathepsin Z’s Role in Prostate Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.